
H-Asp(OtBu)-OH
CAS No. 3057-74-7
H-Asp(OtBu)-OH( —— )
Catalog No. M35883 CAS No. 3057-74-7
H-Asp(OtBu)-OH (L-Aspartic acid 4-tert-butyl ester) is an aspartic acid derivative that can be used in the synthesis of short peptides.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | 30 | In Stock |
![]() ![]() |
500MG | 66 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameH-Asp(OtBu)-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-Asp(OtBu)-OH (L-Aspartic acid 4-tert-butyl ester) is an aspartic acid derivative that can be used in the synthesis of short peptides.
-
DescriptionL-Aspartic acid 4-tert-butyl ester is an aspartic acid derivative.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3057-74-7
-
Formula Weight189.21
-
Molecular FormulaC8H15NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(OC(C)(C)C)=O)[C@@H](C(O)=O)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.?
molnova catalog



related products
-
Escin Iib
Escin IIb, isolated from horse chestnut, the seeds of Aesculus hippocastanum L., has positive effects on acute inflammation in animals.
-
2,4-Dihydroxy-6-meth...
2,4-Dihydroxy-6-methoxyacetophenone exhibits a moderate antispasmodic activity.
-
Ro 31-8220 Mesylate
Ro 31-8220 is a pan-PKC inhibitor for PKC-α/βI/βII/γ/ε (IC50: 5/24/14/27/24 nM), and also shows potent inhibition against MSK1, MAPKAP-K1b, S6K1, and GSK3β.